Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): Effects on mortality at 1 year

Journal of the American College of Cardiology

Volumn 26, Issue 1, 1995, Pages 57-65

  Malmberg, Klas ^a   Rydén, Lars ^a   Efendic, Suad ^a   Herlitz, Johan ^a   Nicol, Peter ^a   Waldenstrom, Anders ^a   Wedel, Hans ^a   Welin, Lennart ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLUCOSE; HEMOGLOBIN A1C; INSULIN; ISUHUMAN BASAL; ISUHUMAN RAPID; NITRATE; PHENETICILLIN; POTASSIUM ION; UNCLASSIFIED DRUG;

ACUTE HEART INFARCTION; ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; GLUCOSE INFUSION; HUMAN; INSULIN TREATMENT; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MORTALITY; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SUBCUTANEOUS DRUG ADMINISTRATION; TREATMENT OUTCOME;

AGED; DIABETES COMPLICATIONS; DIABETES MELLITUS; FEMALE; GLUCOSE; HOSPITAL MORTALITY; HUMANS; INFUSIONS, INTRAVENOUS; INJECTIONS, SUBCUTANEOUS; INSULIN; MALE; MYOCARDIAL INFARCTION; SURVIVAL ANALYSIS;

EID: 0029069020     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/0735-1097(95)00126-K     Document Type: Article

References (70)

1. Myocardial infarction in diabetics
2. Swedish co-operative CCU study
3. Clinical course of myocardial infarction among diabetic patients
4. Myocardial infarction in patients with diabetes mellitus
5. Mortality and morbidity during a five year follow-up of diabetics with myocardial infarction
6. Prognosis of acute myocardial infarction in diabetic and non-diabetic patients
7. Outcome of patients with diabetes mellitus and acute myocardial infarction treated with thrombolytic agents
8. A randomised trial of propranolol in patients with acute myocardial infarction. I. Mortality results
9. Effect on mortality of metoprolol in acute myocardial infarction
10. Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction
11. A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction
12. A comparison of immediate coronary angioplasty with intravenous streptokinase in acute myocardial infarction
13. Mortality trends and causes of death in diabetic patients
14. Trends in prevalence of diabetes mellitus in patients with myocardial infarction and effect of diabetes on survival
15. Severity in coronary artery disease in patients with diabetes mellitus
16. Specific heart disease in diabetes mellitus
17. Cardiac autonomic neuropathy
18. The diabetic heart: metabolic causes for the development of a cardiomyopathy
19. Timolol treatment after myocardial infarction in diabetic patients
20. Effects of metoprolol on mortality and late infarction in diabetics with suspected acute myocardial infarction
21. Clinical experience with glucose-insulin-potassium therapy in acute myocardial infarction
22. Effect of intravenous infusion of insulin in diabetics with acute myocardial infarction
23. Effect of intravenous insulin infusion on mortality among diabetic patients after myocardial infarction
24. Metabolic control in diabetic subjects following myocardial infarction: difficulties in improving blood glucose levels by intravenous insulin infusion
25. Thromboxanc biosynthesis and platelet function in type 11 diabetes mellitus
26. Hemobiology, vascular disease and diabetes with special reference to impaired fibrinolysis
27. Insulin therapy in type 2 diabetic subjects suppresses plasminogen activator inhibitor (PAI-I) activity and proinsulin-like molecules independently of glycaemic control
28. Classifications and diagnosis of diabetes mellitus and other categories of glucose intolerance
29. Feasibility of insulin-glucose infusion in diabetic patients with acute myocardial infarction
30. Determinants of hospital admissions and case fatality in diabetic patients with myocardial infarction
31. Regression models and life-tables
32. Randomised trial of intravenous streptokinase oral aspirin both or neither among 17187 cases of suspected acute myocardial infarction ISIS-2
33. Significance of diabetes mellitus in patients with acute myocardial infarction receiving thrombolytic therapy
34. Influence of diabetes on mortality in acute myocardial infarction: data from the GISSI-2 study
35. Acute myocardial infarction in diabetic patients in the thrombolytic era
36. Diabetic patients and beta-blockers after acute myocardial infarction
37. Serum glucose levels during long-term observation of treated and untreated men with mild hypertension
38. Differences in metabolic responses to beta-adrenergic stimulation after propranolol and metoprolol administration
39. Acebutolol, atenolol and propranolol and metabolic responses to acute hypoglycaemia in diabetes
40. Effect of metoprolol on the counter-regulation and recognition of prolonged hypoglycemia in insulin-dependent diabetics
41. Effect of cardioselective and nonselective β-blockade on the hypoglycemic response in insulin dependent diabetes
42. Effects of propranolol on the hormonal and the metabolic responses to hypoglycemia
43. Hormonal and substrate responses during recovery from hypoglycemia during β1-selective and non-selective beta-adrenergic blockade
44. Effects of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction
45. Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure
46. Serial plasma catecholamine response early in course of clinical acute myocardial infarction: relationship to infarct extent and mortality
47. Initial metabolic and hormonal response to acute myocardial infarction
48. Insulin secretion following myocardial infarction
49. Adreno cortical response to the stress of an acute myocardial infarction
50. Serum glucagon and insulin levels and their relationship to blood glucose values in patients with acute myocardial infarction and acute coronary insufficiency
51. Hormonal control of lipolysis in perfused adipocytes from diabetic rats
52. β-Adrenergic receptors and adenylate cyclase activity in diabetic rat fat cells
53. Relationship between carbohydrate metabolism and energy balance of heart muscle
54. Regulation of glucose uptake in muscle III Rate-limiting step and effects of insulin and anoxia in heart muscle from diabetic rats
55. Fuel selection in animals
56. Metabolism of free fatty acids, glucose and catecholamines in acute myocardial infarction
57. Alterations of carbohydrate and lipid metabolism in the acutely ischemic heart
58. Relation between serum-free-fatty-acids and arrhythmias and death after acute myocardial infarction
59. Relation between plasma free fatty acids and arrhythmias within the first twelve hours of acute myocardial infarction
60. The polarizing treatment of acute myocardial infarction
61. Effects of an intravenous infusion of a potassium-insulin-glucose solution on the electrocardiographic signs of myocardial infarction
62. Mitochondrial biochemical changes and glucose-KCL-insulin solution in cardiac infarct
63. Enhancement of left ventricular function by glucose-insulin-potassium infusion in acute myocardial infarction
64. Prospective randomized trial of glucose-insulin-potassium in acute myocardial infarction
65. Left ventricular regional function after acute anterior myocardial infarction in diabetic patients
66. Residual left ventricular pump function after acute myocardial infarction in NIDDM patients
67. Insulin treatment of patients with type 2 diabetes: risks and benefits
68. Plasminogen activator inhibitor activity in diabetic and nondiabetic survivors of myocardial infarction
69. Cardiomyopathy of overload
70. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus